Author Page for Géraldine Piorkowski

Actions:

View:
Selected
Original List
All Versions Hide All Versions
All Abstracts Hide All Abstracts

(Rank)

Further Preclinical Characterization of Molnupiravir Against SARS-CoV-2: Antiviral Activity Determinants and Viral Genome Alteration Patterns

Number of pages: 32 Posted: 03 Mar 2024

Paul-Rémi Petit, Franck Touret, Jean-Sélim Driouich, Maxime Cochin, Léa Luciani, Ornéllie Bernadin, Caroline Laprie, Géraldine Piorkowski, Laurent Fraisse, Peter Sjo, Charles Mowbray, Fanny Escudié, Ivan Scandale, Eric Chatelain, Xavier de Lamballerie, Caroline Solas and Antoine Nougairède

Aix-Marseille University, Aix Marseille Université - Emerging Viruses Unit, Aix-Marseille University, Aix-Marseille University, Aix-Marseille University, Aix-Marseille University, Laboratoire Vet-Histo, Aix-Marseille University, Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi), Aix Marseille Université - Emerging Viruses Unit, Aix-Marseille University and Aix Marseille Université - Emerging Viruses Unit

Downloads 78 (816,709)

Citation 1

Géraldine Piorkowski

Aix-Marseille University

1

78

1

Scholarly Papers (1)

Further Preclinical Characterization of Molnupiravir Against SARS-CoV-2: Antiviral Activity Determinants and Viral Genome Alteration Patterns

Abstract: